文献速递药物不良反应与药物警戒

COVID-19「信息疫情」对用药行为的影响及其药物警戒启示

The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance.
PubMed 文献 · Drug Saf · 2020-01-01

2020年COVID-19大流行引发大量通过纸媒、广播、网络和社交媒体传播的「信息疫情」,其中包含关于氯喹、羟氯喹、非甾体抗炎药、ACEI、ARB、法匹拉韦和乌米诺韦等药物的耸人听闻和扭曲信息。本文分析这些药物用于COVID-19的主张依据、传播内容、对公众行为的影响以及监管机构的应对,并讨论药物警戒利益相关者在应急管理中的角色和未来类似危机的应对策略。

要点

  • COVID-19信息疫情中关于氯喹、羟氯喹等药物的扭曲信息可能诱导不恰当且危险的使用。
  • 信息疫情先影响意见领袖和社交媒体活跃人群,再扩散影响普通患者用药选择。
  • 药物警戒利益相关者需在应急管理中发挥作用并制定未来类似危机的应对策略。

核心结论

  • COVID-19信息疫情中关于氯喹、羟氯喹、非甾体抗炎药、ACEI、ARB、法匹拉韦和乌米诺韦等药物的传播信息可能导致不恰当且危险的使用。
  • 药物警戒利益相关者在应急管理中具有重要作用,需制定策略应对未来类似危机。

研究设计与样本

  • 本文为针对COVID-19信息疫情中药物相关传播及其对用药行为影响的分析性文章,未报告系统检索范围或样本量。

主要发现

  • 信息疫情通过纸媒、广播、网络和社交媒体传播关于COVID-19药物的耸人听闻和扭曲信息。
  • 这些信息可能先影响意见领袖和社交媒体活跃人群,再影响其他人群,从而影响各地个体患者的用药选择。
  • 传播信息涉及已批准用于其他适应证的药物:氯喹、羟氯喹、非甾体抗炎药、ACEI、ARB、法匹拉韦和乌米诺韦。

临床怎么用

  • 临床药师应关注信息疫情中关于氯喹、羟氯喹等药物的不实传播,警惕患者因误导信息而自行用药的风险。
  • 药物警戒人员需在公共卫生紧急事件中及时识别和应对药物相关错误信息,减少不恰当用药行为。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The coronavirus disease 2019 (COVID-19) pandemic that hit the world in 2020 triggered a massive dissemination of information (an "infodemic") about the disease that was channeled through the print, broadcast, web, and social media. This infodemic also included sensational and distorted information about drugs that likely first influenced opinion leaders and people particularly active on social media and then other people, thus affecting choices by individual patients everywhere. In particular, information has spread about some drugs approved for other indications (chloroquine, hydroxychloroquine, nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, favipiravir, and umifenovir) that could have led to inappropriate and therefore hazardous use. In this article, we analyze the rationale behind the claims for use of these drugs in COVID-19, the communication about their effects on the disease, the consequences of this communication on people's behavior, and the responses of some influential regulatory authorities in an attempt to minimize the actual or potential risks arising from this behavior. Finally, we discuss the role of pharmacovigilance stakeholders in emergency management and possible strategies to deal with other similar crises in the future.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Tuccori M, Convertino I, Ferraro S, et al. The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance. Drug Saf. 2020. PMID: 32572842. doi:10.1007/s40264-020-00965-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。